Pensionfund Sabic’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Pensionfund Sabic’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-23,000	Closed	–	–	206
2021 Q4	$0	Hold	23,000	–	–	﹤0.01%	219
2021 Q3	$0	Hold	23,000	–	–	﹤0.01%	228
2021 Q2	$0	Hold	23,000	–	–	﹤0.01%	208
2021 Q1	$0	Hold	23,000	–	–	﹤0.01%	230
2020 Q4	$52K	Hold	23,000	–	–	0.01%	200
2020 Q3	$52K	Hold	23,000	–	–	0.01%	200
2020 Q2	$82K	Hold	23,000	–	–	0.02%	195
2020 Q1	$87K	Hold	23,000	–	–	0.03%	190
2019 Q4	$69K	Buy	+23,000	New	+$59.8K	0.02%	201

Other funds holding BMY.RT

JCI

Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return

Pensionfund Sabic's BMY.RT Position: Q1 2022 in Review

Pensionfund Sabic sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2022, closing a stake of 23,000 shares.

Pensionfund Sabic first reported a position in BMY.RT in Q4 2019 and held it in 9 quarters. The position peaked at $87K in Q1 2020. 3 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2022.

Pensionfund Sabic reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2022 after selling out during the quarter.
Pensionfund Sabic sold 23,000 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2022.
Pensionfund Sabic first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 9 quarters.
Pensionfund Sabic's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $87K in Q1 2020.
3 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2022.

Based on Pensionfund Sabic's 13F filing for Q1 2022, filed 12 Apr 2022.